I have the report as a PDF with the chromatogram on page two, so I can quote specifics.
I would like the mechanism, because I want to be able to reason about the cases nobody has written about.
I have tried to reason it out from first principles and got to two contradictory conclusions.
Can someone derive this rather than assert it?
Answer first: residual solvent is what remains from the synthesis and purification, it is measured by headspace gas chromatography, and essentially nobody at this tier reports it.
Headspace gas chromatography with flame ionisation or mass spectrometric detection is the standard method. It is inexpensive relative to peptide mapping and is essentially never requested.
More usefully, the guideline classification puts solvents into three classes: class 1 to be avoided, class 2 limited by permitted daily exposure, and class 3 with low toxic potential and a general limit of 0.5 per cent. Dichloromethane and dimethylformamide sit in class 2; acetonitrile is class 2 as well; ethanol and acetone are class 3.
The caveat is that absence of a reported figure is not a low figure; it is an absent measurement.
An odour in the cake is a positive result. Absence of odour proves nothing.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe short version: acetonitrile, dimethylformamide, dichloromethane, ether and trifluoroacetic acid are the candidates, and the guideline classes tell you which matter.
Solid-phase peptide synthesis uses dimethylformamide or N-methylpyrrolidone as the coupling solvent, dichloromethane for washing, trifluoroacetic acid for cleavage, and diethyl ether for precipitation. Purification adds acetonitrile from the mobile phase.
Loss on drying measures everything volatile, including solvent; Karl Fischer titration measures water specifically. On a sample with residual solvent the two disagree, and the size of the gap estimates the solvent content.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Trifluoroacetate is a counter-ion question, not a solvent question. Different test.
The honest answer is that the amounts are usually small and that "usually" is doing the work in that sentence.
Trifluoroacetic acid is a special case: it is present as the counter-ion rather than as a solvent residue, and it is quantified separately by ion chromatography or by fluorine nuclear magnetic resonance.
The part that matters: lyophilisation removes water efficiently and organic solvents less so, particularly high-boiling ones like dimethylformamide, which is why the coupling solvent is the one to worry about.
Solvent classification into three classes with associated limits is published guidance and is the framework the pharmaceutical industry works to.
The published limits apply to licensed products and have no formal application to research supply.
Ask for headspace gas chromatography if it matters. It is cheap and nobody asks.
edited 4 Jul 2024 by tobias_maartens — tightened the wording; no substantive change
To be exact about it, loss on drying and Karl Fischer disagree on a sample with residual solvent, and the direction of the disagreement is the clue.
Residual solvent contributes to gross vial mass in exactly the same way water does, so a vial with three per cent solvent and four per cent water contains seven per cent of things that are not peptide.
Karl Fischer measures water specifically whereas loss on drying measures all volatiles, which is why the two disagree in the presence of solvent.
A gap between loss on drying and Karl Fischer is an estimate of solvent content, not a measurement of it.
Acetonitrile from the gradient and dimethylformamide from the coupling are the two to expect.
Specifically, the relevant framework is the classification of solvents by toxicity into classes with different limits, which is published and freely available.
A cake with any detectable odour has residual solvent. It is not a quantitative test, but a positive result is definitive and a negative one is weak.
Trifluoroacetate as a counter-ion from reverse-phase purification is quantified by ion chromatography or fluorine NMR rather than by headspace methods.
The caveat is that none of this makes a research-grade vial equivalent to a licensed medicine. There is no release testing programme behind it, no pharmacovigilance, and no recourse if it is wrong. Independent testing narrows your uncertainty; it does not eliminate the category difference.
Loss on drying minus Karl Fischer estimates the solvent. Ask for both.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.